Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome
Jorge Berlanga‐Acosta(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Ariana García‐Ojalvo(Centro de Ingeniería Genética y Biotecnología), Diana García del Barco-Herrera(Centro de Ingeniería Genética y Biotecnología), José I Fernández‐Montequín(Instituto de Gastroenterología), Eulogio Pimentel-Vázquez(Centro de Ingeniería Genética y Biotecnología), Yssel Mendoza‐Marí(Western University of Health Sciences), Maday Fernández‐Mayola(Centro de Ingeniería Genética y Biotecnología), Viviana Falcón‐Cama(Centro de Ingeniería Genética y Biotecnología), Calixto Valdés‐Perez, Aleida Urquiza-Rodríguez(Center of Molecular Immunology (Cuba)), Héctor Pérez-Saad(Centro de Ingeniería Genética y Biotecnología), William Savigne-Gutiérrez, Moshe Kulikovsky(Haifa Medical Center)
Cited by 65
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134